Malkan, U. Y. And HAZNEDAROĞLU, İ. C. 2019. Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia. OPEN MEDICINE , vol.14, no.1 , 22-24.

Malkan, U. Y., & HAZNEDAROĞLU, İ. C., (2019). Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia. OPEN MEDICINE , vol.14, no.1, 22-24.

Malkan, MERT, And İBRAHİM CELALETTİN HAZNEDAROĞLU. "Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia," OPEN MEDICINE , vol.14, no.1, 22-24, 2019

Malkan, MERT And HAZNEDAROĞLU, İBRAHİM C. . "Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia." OPEN MEDICINE , vol.14, no.1, pp.22-24, 2019

Malkan, U. Y. And HAZNEDAROĞLU, İ. C. (2019) . "Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia." OPEN MEDICINE , vol.14, no.1, pp.22-24.

@article{article, author={MERT EŞME And author={İBRAHİM CELALETTİN HAZNEDAROĞLU}, title={Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia}, journal={OPEN MEDICINE}, year=2019, pages={22-24} }